Tenecteplase for Stroke at 4.5 to 24 Hours. Reply
N Engl J Med
.
2024 May 9;390(18):1729.
doi: 10.1056/NEJMc2403602.
Authors
Gregory W Albers
1
,
Barbara Purdon
2
,
Bruce C V Campbell
3
Affiliations
1
Stanford University, Palo Alto, CA albers@stanford.edu.
2
Genentech, South San Francisco, CA.
3
University of Melbourne, Parkville, VIC, Australia.
PMID:
38718370
DOI:
10.1056/NEJMc2403602
No abstract available
Publication types
Letter
Comment
MeSH terms
Clinical Trials as Topic*
Fibrinolytic Agents* / therapeutic use
Humans
Sample Size*
Stroke* / drug therapy
Tenecteplase* / therapeutic use
Time-to-Treatment